You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IMiD

Showing 1 - 25 of 154
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Incident IMID in Patients Treated With Biologics and

Not yet recruiting
  • Inflammatory Disease
    • Paris, France
      Hôpital Saint-Antoine
    Jan 23, 2023

    Adalimumab Withdrawal or Continuation on Severity of COVID-19

    Completed
    • Inflammatory Bowel Diseases
    • Rheumatic Disorder
    • Milano, Italy
      Irccs Ospedale San Raffaele
    Jan 30, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

    Active, not recruiting
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • High Dose Methylprednisolone (HDMP)
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jan 12, 2023

    Multiple Myeloma Trial in Boston, Columbus (drug, biological, other)

    Terminated
    • Multiple Myeloma
    • Boston, Massachusetts
    • +1 more
    Nov 14, 2022

    Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma Trial in Canada, United States (drug, procedure,

    Active, not recruiting
    Has Results
    • Stage I Multiple Myeloma
    • +2 more
    • Chicago, Illinois
    • +4 more
    Sep 3, 2022

    Plasma Cell Myeloma, Residual Disease Trial in Chicago (Ixazomib Citrate, Lenalidomide, Dexamethasone)

    Active, not recruiting
    • Plasma Cell Myeloma
    • Residual Disease
    • Ixazomib Citrate
    • +2 more
    • Chicago, Illinois
      University of Chicago
    Oct 5, 2021

    Cystic Fibrosis in Children, Airway Clearance Impairment Trial in Warsaw (Simeox, CCPT)

    Completed
    • Cystic Fibrosis in Children
    • Airway Clearance Impairment
    • Simeox
    • CCPT
    • Warsaw, Poland
      IMiD
    Feb 26, 2021

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,

    Completed
    Has Results
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • High Dose Methylprednisolone (HDMP)
    • +2 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Apr 2, 2021

    Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial

    Active, not recruiting
    • Contiguous Stage II Small Lymphocytic Lymphoma
    • +11 more
    • MOR00208
    • +2 more
    • Columbus, Ohio
      The Ohio State University Comprehensive Cancer Center
    Feb 24, 2022

    IGRA in Screening and Monitoring for TB During Anti TNF Therapy

    Completed
    • Inflammatory Bowel Disease
    • +4 more
      • Hong Kong, Hong Kong
        Prince of Wales Hospital
      Apr 27, 2020

      Real-life Current Standards of Care in Relapsed and/or

      Completed
      • Multiple Myeloma
      • No intervention
      • Tucson, Arizona
      • +85 more
      Dec 20, 2022

      Immune-Mediated Inflammatory Disease Trial in Kópavogur (SK-M11/3A1 Digital health program)

      Not yet recruiting
      • Immune-Mediated Inflammatory Disease
      • SK-M11/3A1 Digital health program
      • Kópavogur, Iceland
        Húðlæknastöðin dermatology clinic
      Oct 26, 2023

      Based on Maintenance Therapy Post Autologous Stem Cell

      Recruiting
      • Multiple Myeloma
      • Autologous Stem Cell Transplant
      • +2 more
      • Tampa, Florida
        Moffitt Cancer Center
      Jul 27, 2022

      Refractory Multiple Myeloma, Smoldering Multiple Myeloma, Stage I Multiple Myeloma Trial in Duarte (radiation, drug, procedure,

      Completed
      Has Results
      • Refractory Multiple Myeloma
      • +4 more
      • total marrow irradiation
      • +8 more
      • Duarte, California
        City of Hope Medical Center
      Feb 25, 2021

      Refractory Multiple Myeloma Trial in Cleveland (azacitidine, lenalidomide, dexamethasone)

      Completed
      Has Results
      • Refractory Multiple Myeloma
      • Cleveland, Ohio
      • +1 more
      Oct 20, 2020

      Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

      Completed
      • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
      • +6 more
      • Buffalo, New York
        Roswell Park Cancer Institute
      Sep 22, 2020

      Multiple Myeloma Trial in Baltimore (MK-3475, Pomalidomide, Dexamethasone)

      Terminated
      Has Results
      • Multiple Myeloma
      • Baltimore, Maryland
        Greenebaum Cancer Center at University of Maryland Medical Cente
      Nov 1, 2019

      ImmuNe-Mediated Inflammatory Diseases Trial in Milan (Questionnaires)

      Not yet recruiting
      • ImmuNe-Mediated Inflammatory Diseases
      • Questionnaires
      • Milan, Italy
        IRCCS Istituto Ortopedico Galeazzi
      Jan 10, 2022

      Recurrent Chronic Lymphocytic Leukemia Trial in Jacksonville, Buffalo (Lenalidomide, R-(-)-Gossypol Acetic Acid, Laboratory

      Terminated
      Has Results
      • Recurrent Chronic Lymphocytic Leukemia
      • Jacksonville, Florida
      • +1 more
      Jun 11, 2020

      Multiple Myeloma Trial in Worldwide (Elranatamab (PF-06863135))

      Active, not recruiting
      • Multiple Myeloma
      • Elranatamab (PF-06863135)
      • Beverly Hills, California
      • +75 more
      Oct 4, 2022

      Hematological Malignancy, Solid Tumor Trial (OT-A201, IMids, Bevacizumab)

      Not yet recruiting
      • Hematological Malignancy
      • Solid Tumor
      • (no location specified)
      Apr 24, 2023

      Diffuse Large B-cell Lymphoma Trial in Worldwide (MOR00208, Lenalidomide)

      Active, not recruiting
      Has Results
      • Diffuse Large B-cell Lymphoma
      • Bakersfield, California
      • +52 more
      Sep 1, 2021

      SARS-CoV-2 Infection Trial in Vitoria (ChAdOx1 nCoV-19 vaccine (AZD1222))

      Recruiting
      • SARS-CoV-2 Infection
      • ChAdOx1 nCoV-19 vaccine (AZD1222)
      • Vitoria, Espirito Santo, Brazil
        Federal University of Espirito Santo
      Nov 23, 2021

      Multiple Myeloma Trial in United States (Magrolimab, Daratumumab, Pomalidomide)

      Recruiting
      • Multiple Myeloma
      • Magrolimab
      • +5 more
      • Tucson, Arizona
      • +8 more
      Jul 28, 2022

      Cystic Fibrosis Trial in Worldwide (ELX/TEZ/IVA, IVA, Placebo (matched to ELX/TEZ/IVA))

      Recruiting
      • Cystic Fibrosis
      • Innsbruck, Austria
      • +89 more
      Dec 20, 2022